News Release

Launch of a "Humanoid Development Project" utilizing physical AI.

Announcement Regarding the Signing of a Naming Rights Sponsorship Agreement for Konoike Sports Park in Nara City

A survey was conducted in Obu City, Aichi Prefecture, regarding the current state of childhood myopia. While approximately 90% of parents intend to take preventative measures, only about 50% actually do so.

Rohto Eye Vision, Japan's only eye care product featuring a BTA formula specifically designed for children's eye inflammation, is now available.

New product launch: "V Rohto Dryguard Premium," an over-the-counter eye drop containing 1% high-molecular-weight chondroitin.

The long-loved "Rohto Pharmaceutical corporate commercial song" has been reborn with an arrangement by world-renowned pianist Hayato Sumino and has begun airing as a time signal in the city.

Kyoto Prefecture's Kizugawa City and Rohto Pharmaceutical Co., Ltd. have signed an agreement regarding the provision of temporary evacuation shelters during disasters.

A wearable medical device for managing symptoms of overactive bladder is set to be launched in the Chinese market.

Elucidation of the involvement of chondroitin sulfate in age-related inflammation of the cornea and conjunctiva

Certified as a "Certified Health & Productivity Management Outstanding Organization (White 500)" for the 9th time in 6 consecutive years